Enciso-Muñoz JM

Idioma: Inglés [English version]
Referencias bibliográficas: 16
Paginas: s173-178
Archivo PDF: 304.66 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Panda SC. Medicine: science or art? Mens Sana Monogr. 2006; 4: 127-138.

2. Morin E. Los siete saberes necesarios para la educación del futuro. Bogotá: UNESCO, 1999, 18-19.

3. Schutzhold V, Hahn J, Tummler K, Klipp E. Computational modeling of lipid metabolism in yeast. Front Mol Biosci. 2016; 3: Article 57.

4. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-2497.

5. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41: 111-188.

6. Anonymous. Lipids, lipoproteins and cardiovascular disease. [visited June 12th, 2021] Available in: https://basicmedicalkey.com/lipids-lipoproteins-and-cardiovascular-disease/

7. Gotto A, Pownall H. Manual of lipid disorders. Filadelfia. Lippincott Williams & Wilkins. 2003.

8. Frank PG, Marcel YL. Apolipoprotein A-I: structure-function relationships. J Lipid Res. 2000; 41: 853-872.

9. Castañer O, Pintó X, Subirana I, Amor AJ, Ros E, Hernáez A et al. Not LDL Cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol. 2020; 76: 2712-2724.

10. Jawi, MM, Frohlich J, Chan SY. Lipoprotein(a) the insurgent: a new insight into the structure, function, metabolism, pathogenicity, and medications affecting lipoprotein(a) molecule. J Lipids. 2020; Article ID 3491764.

11. Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S. Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease. New insights from a large national Biobank. Arterioscler Thromb Vasc Biol. 2021; 41: 465-474.

12. Aru V, Lam C, Khakimov B, Hosefsloot HCJ, Zwanenburg G, Lind MV et al. Quantification of lipoprotein profiles by nuclear magnetic resonance spectroscopy and multivariate data analysis. Trends Analyt Chem. 2017; 94: 210-219.

13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972; 18 (6): 499-502.

14. Wolska A, Remaley AT. Measuring LDL-cholesterol: what is the best way to do it? Curr Op Cardiol. 2020; 35: 405-411.

15. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 73: 3168-3209.

16. Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiol. 2020; 5: 540-548.